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Abstract : In a previous study, we demonstrated that chronic administration of 
systemic glucocorticoids decreases cortical bone mineral density (BMD) and induces 
development of pathologic fractures in asthmatic patients. To investigate cortical bone 
porosity due to glucocorticoids, we studied cortical bone volume, BMD, bone strength, 
and fractures in patients with asthma in this report. 
A total of 82 postmenopausal asthmatic patients were enrolled in the study. 
Vertebral fractures were diagnosed via plain spinal radiograms. Peripheral quantitative 
computed tomography (pQCT) was used to  measure cortical BMD, relative cortical 
volume, and Strength Strain Index (SSI). Multiple regression analysis, Student's t test, 
and other statistical analyses were performed. 
Patients with systemic glucocorticoids therapy had lower cortical BMD, relative 
cortical volume, SSI, and more number of vertebral fractures than patients without it. 
Lifetime cumulative dose of glucocorticoids was related to  cortical BMD, relative 
cortical volume, SSI, and the number of vertebral fractures. The cortical volume- 
density relationship appeared to remain constant regardless of systemic glucocorticoid 
administration. The number of vertebral fractures correlated highly with cortical 
BMD, relative cortical volume, and SSI at  the radius. 
In conclusion, systemic glucocorticoid administration decreases cortical bone density, 
cortical bone volume, and bone strength. G lucocorticoid administration appears to  be 
responsible for the process of cortical bone porosity at  both endosteal and intracortical 
sites. Given that both cortical bone density and volume provide bone strength, cortical 
bone porosity was seen to  contribute to  glucocorticoid-induced bone strength loss and 
fractures. 
Key words : glucocorticoid, cortical bone, pQCT, osteoporosis 
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Introduction 
Recently, techniques for measuring bone 
mineral density (BMD) have been developed. 
Peripheral quantitative computed tomography 
(pQCT) measures three-dimensional density, 
and separately determines both cortical bone 
density and trabecular bone density with a 
high level of precision (0.8 to  1.6% coeffi- 
cient of ~ a r i a t i o n ) ' - ~ ' .  In addition, pQCT is 
able t o  noninvasively estimate bone strength 
based on the theory on the stability of me- 
chanical structures against bending or tor- 
sion'. s'. pQCT on the radius is also known t o  
provide an accurate assessment of the general 
condition of b ~ n e ~ - ~ ' .  Prior t o  the develop- 
ment of pQCT, axial quantitative computed 
tomography (QCT) was used, but this was 
less preciseg' and the cortical shell of verte- 
bral bodies was too thin to  be measured 
accurately1"". Other standard densitometric 
methods, such as dual energy X-ray absor- 
ptiometry (DXA) gave little or no informa- 
tion about bone quality or distribu-tiong'. 
Trabecular bone and cortical bone differ in 
their remodeling  characteristic^^^'^), and struc- 
ture'". Cortical bone is closely related t o  bone 
strength and stiffness7."'. Although the 
strength and stiffness of bone are positively 
correlated with cortical bone density7.l4) ,
cortical bone volume is also known t o  influ- 
ence bone strength4 s .  ll. 15). 
Using pQCT, previous studies have reported 
that aging is associated with a reduction in 
cortical bone volume a s  well as  a reduction in 
cortical bone den~ityl"'~-'~'. Fujii e t  al. demon- 
strated that  a fixed ratio exists between the 
radius cortical volume and density in healthy 
adult humans regardless of either age or sex, 
suggesting that  cortical bone porosity causes 
similar and simultaneous decreases in cortical 
bone volume and density during the aging 
process1'). In secondary hyperparathyoidism, 
similar findings were observed in uremic 
patients on maintenance hemodialysisln. 
Chronic use of systemic glucocorticoids 
(GC) is known t o  lead t o  progressive bone 
loss and the development of pathologic frac- 
tures in a correlating manner with the cumu- 
lative dose of GCB-*. Some patients with 
severe asthma require prolonged oral systemic 
GC therapy despite the development of in- 
haled steroid therapy, -and these patients are 
at a high risk for developing skeletal compli- 
cations due t o  GC therapyw-%). Recently, we 
demonstrated using pQCT that  systemic GC 
administration decreases cortical bone density 
and trabecular bone density in asthmatic 
patients and leads t o  the development of 
pathologic fracturess'. This effect is  most 
pronounced in older patients8'. 
In GGinduced bone loss, however, bone 
strength, cortical volume, and the relation- 
ship between cortical volume and density 
concerning cortical bone porosity have t o  
date never been studied. In the present study, 
we used pQCT t o  measure changes in bone 
strength and cortical bone volume in addi- 
tion t o  cortical and trabecular BMD in 
patients with asthma undergoing systemic 
glucocorticoid therapy. 
Materials and Methods 
SUBJECTS 
Data from 82 outpatients with asthma 
were selected for multiple regression analysis 
in this study. All 82 patients were naturally 
postmenopausal women who had gone 
through menopause at least 10 years prior to  
the s tar t  of the study (mean age: 70.6k5.4 
years, and mean years since menopause: 21.8 
f 6.2) (Table 1). All patients had taken 
61 Cortical bone porosity in steroid-dependent asthma 
inhaled GC (range: 200 to  800 ,U g/day of 
beclomethasone dipropionate; mean: 338 p g/ 
day) over a period of 2 t o  8 years (mean: 4.6 
years). Of the 82 patients with asthma, 60 
were assigned t o  one of two groups for a 
between groups comparison (Table 2). In the 
GC(-) group, 24 patients without systemic 
GC therapy received less than a 0.5 g cumula- 
tive dose of prednisolone. In the GC(+) 
group, 36 patients with systemic GC therapy 
received more than a 10 g cumulative dose of 
prednisolone (mean: equivalent of 24.1 g of 
prednisolone) over a prolonged period (mean: 
9.5 years). There were no significant differ- 
Table 1. Patient Characteristics. 
Age (years) 
Age a t  menapause (years) 
Yean slnce mawpause (years) 
Wght (cm) 
W e w M  (kg) 
BMI (kg/m2) 
Total 8MD (mg/an3) 
Trabecular BMU (mg/cm3) 
Cmtxcal BUD (mg/cm3) 
Relative corbcal volume 
Strength Stram lndu (mm3) 
Number of vertebral fractures 
Cumulative dose of p r e d n i  (g) 15.1 f 24.8 
Values are presented as the mean* SD. 
MI: body mass index; 8MD: bone mheral d & i  
Table 2. Patient Characteristics Divided by Cun 
ences in age, age a t  menopause, years since 
menopause (YSM), height, weight, or  body 
mass Index (BMI) between groups (Table 2). 
Patients who had taken medication tha t  
affects bone metabolism or  patients with 
medical conditions tha t  affect bone metabo- 
lism were excluded from the study. No 
patient had undergone treatment for osteopo- 
rosis, such as  hormone replacement therapy. 
No patient had alcohol dependency, and no 
patient was a smoker. A history was taken, 
and a physical examination was performed on 
all patients. Duration, daily dose, and life- 
time cumulative dose of GC were calculated 
from medical records and a patient's personal 
records. The dose of GC is expressed in 
equivalent grams of prednisolone. 
METHODS 
All patients were evaluated for the presence 
of vertebral deformities on lateral lumbar 
and thoracic radiographs. A vertebral frac- 
ture was defined a s  an altered morphology 
and a decrease in vertebral height of approxi- 
mately 25% or  more a t  the anterior, middle, 
or  posterior aspect of the vertebral body. 
pQCT was performed on the non-dominant 
radius using a Stratec XCT 960 (Nishimoto, 
nulative Dose of Glucocorticoid Use 
GC(-) group (n=24) GC(+) group (n=36) t test 
Age (years) 71.0f4.6 6 9 . 3 f  5.4 N.S. 
Age at menopause (years) 
Years since menopause (years) 
Height (cm) 
Weight (kg) 
BMI (kg/mz) 
47 .5 f  5.5 N.S. 
21.7f  6.6 N.S. 
1 48.3 f 5.2 N.S. 
4 9 . 9 f  5.8 N.S. 
22.7f  2.6 N.S. 
Cumulative dose of prednisolone (g) 0 . 0 8 f  0.1 9 24.1 f 25.9 p< 0.01 
Values are presented as the mean* SD. 
GC: glucocorticoids; BMI: body m s s  index; BMD: bone mineral de-nsii N.S.: not significant 
a: patients without systemic GC therapy who received less than a 0.59 cumulative dose of predniione 
b: patients with syternic GC therapy who received more than a 1 Og cumulative dose of predonisdone 
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Tokyo, Japan), as  described p r e v i o u ~ l y ~ ~ ~ .  
Briefly, the ultradistal radial 4% site (a t  4% 
of the ulnar length proximal t o  the distal end 
of the radius) was used t o  calculate 
trabecular BMD and total  BMD, while the 
mid-radial 20% site was used t o  calculate 
cortical BMD. Constant threshold levels were 
used for all subjects (0.5 mg/cd for total 
bone and 0.93 mg/cd for cortical bone). 
Total and cortical area were estimated 
based on voxel number a t  the mid-radial 20% 
site region, and relative cortical volume, 
defined as  cortical volume divided by the 
total  bone volume, was calculated by dividing 
cortical area with total  area, as described 
pre~iously' ' .~~). 
Determination of bone strength was based 
on calculation of the cross-sectional moment 
of inertia divided by the maximum distance 
of any voxel from, the center of gravity. 
This section modulus represents the geometri- 
cal properties of the bone and is directly 
proportional to  the maximum stress in the 
bone. The material properties were not meas- 
ured directly but estimated by multiplying 
the section modulus by the normalized corti- 
cal density (to a normal physiological density 
of 1200 mg/cd). By combining these geomet- 
rical and material properties, we calculated 
the Strength Strain Index (SSI) values4 '. 16). 
This index was calculated for the mid-radial 
20% site region, and the default threshold 
setting of 0.7 mg/cd was used in relation to  
the amount of cortical bone present, as 
described previously '. 16). 
Statistical analysis 
Student's t test, multiple regression analy- 
sis, and other statistical analyses were per- 
formed using the software package, StatView 
(Abacus Concepts, Berkeley, CA, USA). A p 
value < 0.05 was considered to  be signifi- 
cant. 
Results 
In all 82 patients, multiple regression 
analysis was performed for total  BMD, 
trabecular BMD, cortical BMD, relative 
cortical volume, SSI, and the number of 
vertebral fractures t o  determine the predic- 
tive value of the following variables : YSM, 
lifetime cumulative dose of GC, and BMI. 
Multiple regression analysis demonstrated 
significant relationships (p< 0.0001) between 
each of these variables and total ,  trabecular, 
and cortical BMD, relative cortical volume, 
SSI, and the number of vertebral fractures. 
YSM was significantly correlated with corti- 
cal BMD, relative cortical volume, and SSI 
(Table 3, 4). Lifetime cumulative dose of 
GC was significantly correlated with total  
BMD, trabecular BMD, cortical BMD, rela- 
tive cortical volume, SSI, and the number of 
vertebral fractures (Table 3, 4, 5). BMI was 
significantly correlated with total  BMD, 
trabecular BMD, and relative cortical volume 
(Table 3, 4). 
Spearman's rank correlation test was per- 
formed on all 82 patients, and the number of 
vertebral fractures was seen to  be signifi- 
cantly correlated ( p  < 0.0001) with cortical 
BMD, relative cortical volume, and SSI a t  
the radius. 
Significant differences ( p  < 0.01) were 
observed between the GC(+) group and the 
GC(-) group in total  BMD, trabecular BMD, 
cortical BMD, relative cortical volume, SSI, 
and the number of vertebral fractures (Table 
6). 
A significant correlation between relative 
cortical volume and cortical BMD showing a 
rectilinear relationship was observed in both 
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Table 3. Prediction of Bone Mineral Density by Multiple Regression Analysis. 
Total BMD (RZ= 0.383) Trabecular BMD (RZ= 0.31 3) Cortical BMD (R'= 0.554) 
Predictor Regression SE p-value Regression SE p-value Regression SE p-value 
Variable Coefficient Coefficient Coefficient 
YSM -1.579 0.891 0.0803 -0.31 0.504 0.5405 -3.190 0.754 < 0.0001 
Cumulative PSL -0.001 0.0002 0.0007 -0.0005 0.0002 0.0003 -0.001 0.0002 < 0.0001 
BMI 6.184 1.610 <0.0001 3.765 1.095 0.0009 1.508 1.632 0.3584 
BMD: bone mineral density, SE: standard error; 
YSM: Years since menopause; BMI: body mass index; PSL; prednisolone 
Table 4. Prediction of pQCT Parameters by Multiple Regression Analysis. 
SSl (R'= 0.263) Relative Cortical Volume (R'= 0.486) 
Predictor Regression SE p-value Regression SE p-value 
Variable Coefficient Coefficient 
YSM -2.530 0.790 0.0020 -0.351 0.099 0.0007 
Cumulative PSL -0.001 0.0002 0.01 25 -0.0001 0.00003 < 0.0001 
BMI 3.251 1.709 0.0609 0.699 0.21 4 0.001 7 
SE: standard error; YSM: Years since menopause; 
BMI: body mass index; PSL; prednisolone; SSI: Strength Strain index 
the GC(-) group (p< 0.0001, r2 = 0.772) and 
the GC(+) group (p< 0.0001, r2 = 0.727) 
(Figure 1). 
No significant differences were observed in 
the two cortical volume-density slopes of 
patients with or without systemic GC ther- 
apy. 
Discussion 
In women, there is an irreversible and 
substantial loss of bone consequent t o  the 
lack of estrogen in the 10 year period follow- 
ing menopausen'. Previous reports have de- 
tected perimenopausal bone loss in both 
trabecular and cortical bone using pQCT1''. In 
a previous report, we demonstrated tha t  
systemic GC administration decreases the 
density of both trabecular and cortical bone, 
and t h a t  this effect is  most pronounced in 
older patients8'. In tha t  report, however, 
Table 5. Prediction of Vertebral fractures by 
Multiple Regression Analysis. 
Vertebral fractures (R'= 0.49 1 ) 
Predictor Regression SE p-value 
Variable Coefficient 
YSM 0.034 0.025 0.1795 
Cumulative PSL 0.00005 0.000006 < 0.0001 
BMI -0.059 0.054 0.2786 
SE: standard error; YSM: Years since menopause; 
BMI: body mass index; PSL; prednisolone 
confounding with multiple regression, we 
gave little consideration t o  the influence of 
menopause8'. In the present study, t o  exclude 
the influence of perimenopausal bone loss 
consequent t o  a lack of estrogen, we exam- 
ined female patients who had gone through 
menopause more than ten years prior t o  the 
study. 
In the present study, we have demonstrated 
that  systemic GC administration decreases 
although gender was corrected for potential the density of both trabecular and cortical 
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Table 6. Comparison Within Patient Sub-groups. 
GC(-) group a (n=24) GC(+) group (n=36) t test 
Total BMD (mg/cm3) 31 7 .7f  68.6 255.7f40.3 p< 0.01 
Trabecular BMD (mg/cm3) 142.2f27.1 98.1 f 21.0 p< 0.01 
Cortical BMD (mg/cm3) 1096.5f 44.1 1048.5f 50.0 p< 0.01 
Relative cortical volume 0.486f0.061 0.407f 0.061 p< 0.01 
Strength Strain Index (mrn3) 207.2f 40.8 162.9f 52.4 p< 0.01 
Number of vertebral fractures 0.1 3 f  0.61 1.61 f 1.57 p< 0.01 
Values are presented as the meaniSD. 
BMD: bone mineral density; GC: glucocorticoids; 
a: patients without systemic GC therapy who received less than a 0.59 cumulative dose of prednisolone 
b: patients with syternic GC therapy who received more than a 1 Og cumulative dose of predonisolone 
bone and induces development of pathologic 8o , 
fractures according t o  multiple regression 
- 70 Y = -84.674 + 0.122 X :  R2 = 0.772 
analysis (Table 3, 5), and that  patients with 9 
60 
continuous systemic GC therapy have both ,o 
+ 
low trabecular and cortical BMD and numer- $ 50 
ous fractures according t o  a comparison : 40 
.- 
between groups (Table 6). The findings of 5 30 
a, 
this report confirm tha t  GC administration .727 
20 
causes both types of bone loss and pathologic 800 850 900 950 1000 1050 1100 1150 1200 1250 
Cort i ca l Dens i t y  (mg/cm3) fractures8'. 
The present study has also shown that  Fig. 1. Relationship between cortical density 
systemic GC administration decreases cortical 
bone volume and bone strength (Table 4, 6). 
Given that  both cortical bone density and 
cortical bone volume provide bone stren- 
gth4. 5 .  7 .  11. 1s) , the GC-induced bone strength 
loss and fractures appear t o  correlate with 
the reduction in both cortical density and 
cortical volume. 
Aging is reportedly associated with a re- 
duction in cortical volume due t o  a widening 
of the marrow cavity a s  well as a reduction 
in cortical density1'-" 16'. Using pQCT, Fujii 
e t  al. previously reported that  the radius 
cortical volume and density are rectilinearly 
correlated in the aging processes of healthy 
adult humans"'. Similar findings have also 
been reported in secondary hyperparathy- 
and relative cortical volume in pa- 
tients with asthma. 
A highly significant correlation (p 
< 0.001) of r2  = 0.727 was obtained 
in 36 patients with systemic glucocor- 
ticoid therapy who received more 
than a log cumulative dose of predo- 
nisolone (0 ). A highly significant 
correlation (p < 0.001) of r2  = 0.772 
was also obtained in 24 patients 
without systemic glucocor-ticoid ther- 
apy (@) . Relative cortical volume 
(%) and cortical BMD showing a 
rectilinear relationship was expressed 
as  Y = 0.105(f 0.011)X - 68.953(+ 
11.881) in the 36 patients with sys- 
temic GC therapy, and Y = 0.122 
(f 0.014)X - 84.674( f 15.447) in the 
oidism in uremic patients on maintenance 24 patients without systemic GC ther- 
hemodialysisl". To date, no studies have apy. 
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examined whether this correlation is valid for 
patients who suffer from GC-induced bone 
loss. 
We have demonstrated that  the radius 
cortical bone volume and density are recti- 
linearly correlated in asthmatic patients, 
regardless of the level of systemic GC ther- 
apy (Figure 1). The two cortical volume- 
density slopes in Figure 1 of patients with or 
without continuous systemic GC therapy 
appear largely identical. These slopes are also 
roughly identical to  the slope for healthy 
adult humans in the previous repor"'. In view 
of the highly significant correlation between 
relative cortical volume and density in the 
radial cortex, a single process of GC-induced 
cortical bone resorption, or so-called cortical 
porosity, appears to  be responsible at both 
the endosteal and intracortical sites for 
causing similar and simultaneous decreases in 
cortical bone volume and density, as  in the 
aging proces~es'~' , or in secondary hyper- 
parathyoidism in uremic patients on mainte- 
nance hemodialysis"'. 
Although i t  is still difficult t o  non- 
invasively image three-dimensional cortical 
bone micro-architecture, a s  in microcomputed 
tomography ( ,U CT) imaging of trabecular 
boneg', we believe that  the progress made for 
various techniques will make such imaging 
possible in the future, and that  imaging of 
cortical bone micro-architecture will contrib- 
ute t o  the prediction of biomechanical proper- 
ties. 
In conclusion, systemic GC administration 
decreases both cortical bone density and 
cortical bone volume, and ultimately de- 
creases bone strength. GC administration 
appears responsible for the process of cortical 
bone porosity a t  both the endosteal and 
intracortical sites, and thus causes similar 
and simultaneous decreases in cortical bone 
volume and density. This cortical bone poros- 
ity ultimately contributes t o  GCinduced bone 
strength loss and fractures. 
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【目的】骨強度には皮質骨の状態が主に関与する  
ため，全身ステロイド療法に伴う病的骨折と皮質  
骨障害について検討した。【方法】閉経後女性気  
管支喘息患者82例で，ステロイド依存性群と非依  
存群において，椎体骨折数，槙骨皮質骨骨密度，  
皮質骨容量，骨強度（SSI）をⅩ線側面像とpQCT  
を用いて検討した。【結果】ステロイド依存群は  
ステロイド非依存群に比べて，椎体圧迫骨折数は  
有意に多く，榛骨皮質骨骨密度，皮質骨容積比，  
骨強度は各々有意に低下していた。また，皮質骨  
骨密度と容積は一定の割合で減少していた。椎体  
圧迫骨折数は皮質骨骨密度，皮質骨容積比，骨強  
度の全てと高い相関を認めた。【結論】ステロイ  
ド依存性気管支暗息症例においては，皮質骨の骨  
密度と容量が同時に減少して骨強度が減少するこ  
とによって，病的骨折が発症すると考えられた。   
